GHRS · GH Research PLC
$28.10
-0.23 (-0.81%)
At close · Aug 24
Market Cap
$1.94B
Shares
68.64M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$28.10
Open$28.20
Day$27.24–28.60
52W close$11.94–30.64
Avg vol 30d342K
Short int2.5M · 3.7% float · 7.3d
Short vol61%
DataJun 2021–Aug 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.9 · calm
Equity put/call 0.68
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+46%
above
Price vs 50-day avg
+4%
above
RSI (14)
48
neutral
MACD trend
Negative
52-week position
86%
near high
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+84%
trailing
YTD return
+121%
this year
Relative strength
+71%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $27 › 200d $19 — 50d above 200d
Institutional flow
Accumulating
+17% holders QoQ · +19 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.69% of float · ▲ +30.0% MoM · 7.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
63 holders — near 3-yr high, broad support
Squeeze score
72
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
73%
annualized · 1-yr
Max drawdown
−27%
past year
ATR
5.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+46%
Bullish
Price vs 50-day avg
+4%
Bullish
RSI (14)
48
Neutral
MACD trend
Negative
Bearish
52-week position
86%
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $27 › 200d $19 — 50d above 200d
Institutional flow
Accumulating
+17% holders QoQ · +19 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.69% of float · ▲ +30.0% MoM · 7.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
63 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $12
Now $28 · 86%
Range high $31
vs 200-day avg +46%
vs 50-day avg +4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GHRS
this stock
GH Research PLC
|
$1.94B | +121.3% | — | — | 3.7% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.91B | +20.8% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$85.30B | +7.3% | +20.8% | 20.5 | 3.3% |
|
ARGX
Argenx SE
|
$64.66B | +20.2% | — | — | 2.1% |
|
CSLLY
Csl Ltd
|
$57.97B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GHRS | -6.3% | +1.3% | +83.7% | +0.1% | +121.3% |
| SPY | -1.2% | +3.3% | +12.2% | +2.2% | +12.0% |
| vs SPY | -5.1% | -2.0% | +71.4% | -2.1% | +109.3% |
Key facts
CIK
1855129
CUSIP
G3855L106
13F (30d)
62 filings
60 filers
Visit website
Investor relations